ERIS Lifesciences Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 54.74% of ERIS Lifesciences, FIIs hold 5.74%, DIIs hold 20.19% and the public holds 19.32%. Promoter holding rose by 0.60 percentage points from Jun 2026.
Get an alert when ERIS Lifesciences reports results or its shareholding changes. Free account.
Promoters
54.74%
+0.60 pp QoQ
FIIs
5.74%
−0.02 pp QoQ
DIIs
20.19%
−0.52 pp QoQ
Public
19.32%
−0.07 pp QoQ
ERIS Lifesciences shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 54.74% | 5.74% | 20.19% | 19.32% | 49,034 |
| Jun 2026 | 54.14% | 5.76% | 20.71% | 19.39% | 50,798 |
| Mar 2026 | 53.92% | 6.39% | 20.35% | 19.33% | 51,656 |
| Dec 2025 | 54.85% | 6.85% | 20.31% | 17.97% | 54,713 |
| Sep 2025 | 54.85% | 7.21% | 19.36% | 18.57% | 59,438 |
| Jun 2025 | 54.83% | 8.39% | 18.18% | 18.59% | 52,225 |
| Mar 2025 | 54.85% | 8.43% | 18.07% | 18.64% | 50,087 |
| Dec 2024 | 54.86% | 8.36% | 18.07% | 18.73% | 53,314 |
| Sep 2024 | 54.87% | 8.01% | 18.64% | 18.47% | 46,346 |
| Jun 2024 | 54.88% | 14.59% | 16.23% | 14.30% | 44,176 |
| Mar 2024 | 54.90% | 14.27% | 15.63% | 15.20% | 51,753 |
| Dec 2023 | 54.90% | 13.13% | 14.55% | 17.41% | 46,496 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹18.17k cr, the promoter group's 54.74% stake is worth ₹9.94k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
ERIS Lifesciences shareholding: common questions
What is the promoter holding in ERIS Lifesciences?
Promoters hold 54.74% of ERIS Lifesciences as of Sep 2026. Their stake rose by 0.60 percentage points from Jun 2026.
How much do FIIs hold in ERIS Lifesciences?
Foreign institutional investors (FIIs) held 5.74% of ERIS Lifesciences in Sep 2026, −0.02 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in ERIS Lifesciences?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 20.19% of ERIS Lifesciences in Sep 2026, −0.52 pp versus Jun 2026.
Is the promoter holding in ERIS Lifesciences pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in ERIS Lifesciences.
How has ERIS Lifesciences's promoter holding changed in the last year?
Promoter holding moved from 54.85% in Sep 2025 to 54.74% in Sep 2026 (−0.11 pp).
How many shareholders does ERIS Lifesciences have?
ERIS Lifesciences had 49,034 shareholders in Sep 2026, compared with 50,798 in Jun 2026.